[{"address1": "12278 Scripps Summit Drive", "city": "San Diego", "state": "CA", "zip": "92131", "country": "United States", "phone": "858 875 1800", "website": "https://www.fatetherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma; FT836 whiuch is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, and FT825 to treat solid tumors.It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.", "fullTimeEmployees": 181, "companyOfficers": [{"maxAge": 1, "name": "Dr. Bahram  Valamehr M.B.A., Ph.D.", "age": 47, "title": "President, CEO & Director", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 676600, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Cindy R. Tahl J.D.", "age": 51, "title": "Chief Legal & Compliance Officer and Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 644600, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Victor  Hong", "title": "Vice President of Corporate Development & Finance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jessica  Francis", "title": "Vice President Of Human Resources & Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  Henry", "age": 60, "title": "Senior Vice President of Clinical Operations", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tunde  Babalola", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Yu  Cai", "title": "Head of Intellectual Property & Assistant General Counsel", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kate  Duvall", "title": "Corporate Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 4, "compensationRisk": 10, "shareHolderRightsRisk": 10, "overallRisk": 10, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.32, "open": 1.31, "dayLow": 1.21, "dayHigh": 1.325, "regularMarketPreviousClose": 1.32, "regularMarketOpen": 1.31, "regularMarketDayLow": 1.21, "regularMarketDayHigh": 1.325, "payoutRatio": 0.0, "beta": 2.325, "forwardPE": -0.72023815, "volume": 1329668, "regularMarketVolume": 1329668, "averageVolume": 2031965, "averageVolume10days": 1590390, "averageDailyVolume10Day": 1590390, "bid": 1.21, "ask": 1.28, "bidSize": 1, "askSize": 14, "marketCap": 138705936, "fiftyTwoWeekLow": 0.66, "fiftyTwoWeekHigh": 5.92, "priceToSalesTrailing12Months": 10.401645, "fiftyDayAverage": 1.0624, "twoHundredDayAverage": 2.0245, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -18387044, "profitMargins": 0.0, "floatShares": 92330021, "sharesOutstanding": 114633000, "sharesShort": 12870954, "sharesShortPriorMonth": 15586689, "sharesShortPreviousMonthDate": 1744675200, "dateShortInterest": 1747267200, "sharesPercentSharesOut": 0.11229999, "heldPercentInsiders": 0.01737, "heldPercentInstitutions": 0.94279, "shortRatio": 6.27, "shortPercentOfFloat": 0.1282, "impliedSharesOutstanding": 114633000, "bookValue": 2.517, "priceToBook": 0.48073104, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -175879008, "trailingEps": -1.49, "forwardEps": -1.68, "enterpriseToRevenue": -1.379, "enterpriseToEbitda": 0.109, "52WeekChange": -0.67029977, "SandP52WeekChange": 0.1189177, "quoteType": "EQUITY", "currentPrice": 1.21, "targetHighPrice": 12.0, "targetLowPrice": 2.0, "targetMeanPrice": 5.6875, "targetMedianPrice": 4.5, "recommendationKey": "none", "numberOfAnalystOpinions": 8, "totalCash": 240424992, "totalCashPerShare": 2.097, "ebitda": -168276992, "totalDebt": 83329000, "quickRatio": 8.695, "currentRatio": 8.815, "totalRevenue": 13335000, "debtToEquity": 28.893, "revenuePerShare": 0.113, "returnOnAssets": -0.23973, "returnOnEquity": -0.4923, "grossProfits": -102194000, "freeCashflow": -76877376, "operatingCashflow": -123333000, "revenueGrowth": -0.154, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -25.3407, "financialCurrency": "USD", "symbol": "FATE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Fate Therapeutics, Inc.", "longName": "Fate Therapeutics, Inc.", "corporateActions": [], "postMarketTime": 1748648863, "regularMarketTime": 1748635201, "exchange": "NGM", "messageBoardId": "finmb_39268712", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -8.33333, "regularMarketPrice": 1.21, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1380634200000, "postMarketChangePercent": 2.47934, "postMarketPrice": 1.24, "postMarketChange": 0.03, "regularMarketChange": -0.11, "regularMarketDayRange": "1.21 - 1.325", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 2031965, "fiftyTwoWeekLowChange": 0.55, "fiftyTwoWeekLowChangePercent": 0.8333333, "fiftyTwoWeekRange": "0.66 - 5.92", "fiftyTwoWeekHighChange": -4.71, "fiftyTwoWeekHighChangePercent": -0.7956081, "fiftyTwoWeekChangePercent": -67.029976, "earningsTimestamp": 1747166460, "earningsTimestampStart": 1755028800, "earningsTimestampEnd": 1755028800, "earningsCallTimestampStart": 1715288400, "earningsCallTimestampEnd": 1715288400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.49, "epsForward": -1.68, "epsCurrentYear": -1.262, "priceEpsCurrentYear": -0.9587956, "fiftyDayAverageChange": 0.14760005, "fiftyDayAverageChangePercent": 0.13893078, "twoHundredDayAverageChange": -0.81449986, "twoHundredDayAverageChangePercent": -0.40232152, "displayName": "Fate Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-05-31"}]